Description

A comprehensive cardiovascular risk profile with a vitamin D blood panel can help assess your risk of cardiovascular disease (CVD). A vitamin D blood panel measures the level of 25-hydroxyvitamin D (25(OH)D) in your blood. Low levels of 25(OH)D are associated with an increased risk of CVD. 

Test included:

  • HDL CHOLESTEROL
  • CALC NON-HDL CHOL
  • CALC LDL CHOL
  • CHOLESTEROL
  • TRIGLYCERIDES
  • HOMOCYSTEINE
  • LIPOPROTEIN
  • VITAMIN D, 25 OH
  • HIGH SENSITIVITY CRP
  • PLAC TEST

Fasting recommended.

Lipid Profile:

A standard lipid profile measures levels of total cholesterol, low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, and triglycerides. These markers are essential for assessing the risk of atherosclerosis and other cardiovascular conditions.

High-Sensitivity C-Reactive Protein (hs-CRP):

Hs-CRP is an inflammatory marker that indicates the presence of inflammation in the body. Elevated levels of hs-CRP are associated with an increased risk of cardiovascular events and can provide additional risk stratification beyond traditional lipid measurements.

Apolipoprotein B (ApoB):

ApoB is a protein found in LDL and very low-density lipoprotein (VLDL) particles. It is a more accurate marker of the number of atherogenic particles in the blood, offering a better assessment of cardiovascular risk than LDL cholesterol levels alone.

Lipoprotein(a) [Lp(a)]:

Lp(a) is a lipoprotein variant that is genetically determined. Elevated levels of Lp(a) are linked to a higher risk of cardiovascular disease, independent of other lipid parameters. Measuring Lp(a) can help identify individuals at increased risk who may benefit from more aggressive risk management strategies.

Homocysteine:

Homocysteine is an amino acid that, when elevated, is associated with an increased risk of cardiovascular disease. High homocysteine levels can damage blood vessels and promote the formation of blood clots.

PLAC Test:

The PLAC test measures the levels of lipoprotein-associated phospholipase A2 (Lp-PLA2), an enzyme associated with vascular inflammation and plaque instability. Elevated Lp-PLA2 levels indicate a higher risk of cardiovascular events, making the PLAC test a valuable addition to the risk assessment panel.